Blood Glucose Patents (Class 600/347)
  • Patent number: 7885699
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: August 6, 2010
    Date of Patent: February 8, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 7885697
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: February 8, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Paul V. Neale, James H. Brauker, James Patrick Thrower
  • Patent number: 7881763
    Abstract: An implantable sensor for use in measuring a concentration of an analyte such as glucose in a bodily fluid, including a body with a sensing region adapted for transport of analytes between the sensor and the bodily fluid, wherein the sensing region is located on a curved portion of the body such that when a foreign body capsule forms around the sensor, a contractile force is exerted by the foreign body capsule toward the sensing region. The body is partially or entirely curved, partially or entirely covered with an anchoring material for supporting tissue ingrowth, and designed for subcutaneous tissue implantation. The geometric design, including curvature, shape, and other factors minimize chronic inflammatory response at the sensing region and contribute to improved performance of the sensor in vivo.
    Type: Grant
    Filed: May 2, 2006
    Date of Patent: February 1, 2011
    Assignee: DexCom, Inc.
    Inventors: James H. Brauker, Victoria Carr-Brendel, Paul V. Neale, Laura A. Martinson, Mark A. Tapsak
  • Patent number: 7879213
    Abstract: A process for the manufacture of small sensors with reproducible surfaces, including electrochemical sensors. One process includes forming channels in the surface of a substrate and disposing a conductive material in the channels to form an electrode. The conductive material can also be formed on the substrate by other impact and non-impact methods. In a preferred embodiment, the method includes cutting the substrate to form a sensor having a connector portion and a transcutaneous portion, the two portions having edges that define one continuous straight line.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: February 1, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke
  • Patent number: 7878975
    Abstract: An apparatus for indicating a health-related condition of a subject has an input interface for receiving a sequence of samples of a first biological quantity derived by a first measurement method, the first measurement method being an invasive measurement and having a first impact on the subject, and for receiving a sequence of samples of a second biological quantity derived by a second measurement method, the second measurement method being a non-invasive measurement and having a second impact on the subject, wherein the first biological quantity gives a more accurate indication of the health-related condition of the subject than the second biological quantity, wherein the first biological quantity and the second biological quantity have a correlation to the health-related condition of the subject, and wherein the second impact is smaller than the first impact; a predictor for providing, for a certain time, for which no sample for the first biological quantity exists, an estimated value of the first biologic
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: February 1, 2011
    Assignee: Diabetes Tools Sweden AB
    Inventors: Lars Gustaf Liljeryd, Ulf Frederik Magnusson
  • Publication number: 20110021895
    Abstract: A small diameter flexible electrode designed for subcutaneous in vivo amperometric monitoring of glucose is described. The electrode is designed to allow “one-point” in vivo calibration, i.e., to have zero output current at zero glucose concentration, even in the presence of other electroreactive species of serum or blood. The electrode is preferably layered, with the layers serially deposited within a recess upon the tip of a polyamide insulated gold wire. A first glucose concentration-to-current transducing layer can be overcoated with an electrically insulating and glucose flux limiting layer (second layer) on which, optionally, an immobilized interference-eliminating horseradish peroxidase based film is deposited. An outer layer is preferably biocompatible.
    Type: Application
    Filed: September 29, 2010
    Publication date: January 27, 2011
    Inventors: Adam Heller, Michael V. Pishko
  • Publication number: 20110021896
    Abstract: Novel membranes comprising various polymers containing heterocyclic nitrogen groups are described. These membranes are usefully employed in electrochemical sensors, such as amperometric biosensors. More particularly, these membranes effectively regulate a flux of analyte to a measurement electrode in an electrochemical sensor, thereby improving the functioning of the electrochemical sensor over a significant range of analyte concentrations. Electrochemical sensors equipped with such membranes are also described.
    Type: Application
    Filed: September 30, 2010
    Publication date: January 27, 2011
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Fei Mao, Hyun Cho
  • Patent number: 7874985
    Abstract: A method, system, and computer program product related to the diagnosis of diabetes, and is directed to predicting the long-term risk of hyperglycemia, and the long-term and short-term risks of severe hypoglycemia in diabetics, based on blood glucose readings collected by a self-monitoring blood glucose device. The method, system, and computer program product pertain directly to the enhancement of existing home blood glucose monitoring devices, by introducing an intelligent data interpretation component capable of predicting both HbA1c and periods of increased risk of hypoglycemia, and to the enhancement of emerging continuous monitoring devices by the same features. With these predictions the diabetic can take steps to prevent the adverse consequences associated with hyperglycemia and hypoglycemia.
    Type: Grant
    Filed: December 19, 2005
    Date of Patent: January 25, 2011
    Assignee: University of Virginia Patent Foundation
    Inventors: Boris P. Kovatchev, Daniel J. Cox
  • Publication number: 20110015508
    Abstract: Method and apparatus for providing multiple data receiver units in a data monitoring and management system such as analyte monitoring system where a first data receiver includes all of the functionalities for the data monitoring and management system receiver unit, and a second data receiver unit is configured with a limited functions to provide application specific convenience to the user or patient is disclosed.
    Type: Application
    Filed: September 23, 2010
    Publication date: January 20, 2011
    Applicant: Abbott Diabetes Care Inc.
    Inventor: Thomas Peyser
  • Publication number: 20110015509
    Abstract: Method and apparatus for providing multiple data receiver units in a data monitoring and management system such as analyte monitoring system where a first data receiver includes all of the functionalities for the data monitoring and management system receiver unit, and a second data receiver unit is configured with a limited functions to provide application specific convenience to the user or patient is disclosed.
    Type: Application
    Filed: September 23, 2010
    Publication date: January 20, 2011
    Applicant: Abbott Diabetes Care Inc.
    Inventor: Thomas Peyser
  • Publication number: 20110015510
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: September 27, 2010
    Publication date: January 20, 2011
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 7871456
    Abstract: A membrane for use in an implantable glucose sensor including at least one crosslinked substantially hydrophobic polymer and at least one crosslinked substantially hydrophilic polymer; wherein the first and second polymers are different polymers and substantially form an interpenetrating polymer network, semi-interpenetrating polymer network, polymer blend, or copolymer. The membranes are generally characterized by providing a permeability ratio of oxygen to glucose of about 1 to about 1000 in units of (mg/dl glucose) per (mmHg oxygen). Three methods of making membranes from hydrophobic and hydrophilic monomers formed into polymer networks are provided, wherein according to at least two of the methods, the monomers may be substantially immiscible with one another.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: January 18, 2011
    Assignee: The Regents of the University of California
    Inventors: David A. Gough, Joseph Y. Lucisano, Joe T. Lin, Hwai-Min Tsay, Drahoslav Lim, Jana Limova, legal representative
  • Patent number: 7872399
    Abstract: A variance in transmitting/receiving sensitivity between multiple vibrational elements or transducers included in an ultrasonic probe is corrected. An ultrasonic probe in accordance with the present invention has multiple transducers, each of which includes multiple vibrational elements that each transmit or receive ultrasonic waves by converting ultrasonic waves and an electric signal into each other with a bias voltage applied thereto, set in array. The ultrasonic prove includes a transmitting/receiving sensitivity correction means that independently adjusts the bias voltage to be applied to at least two vibrational elements among the multiple vibrational elements so as to correct a variance in transmitting/receiving sensitivity between the at least two vibrational elements.
    Type: Grant
    Filed: November 10, 2006
    Date of Patent: January 18, 2011
    Assignee: Hitachi Medical Corporation
    Inventors: Masanao Kondou, Katsunori Asafusa
  • Patent number: 7871376
    Abstract: Method for treating a medical condition in a human patient comprising choosing a psychological strategy for treating the medical condition, encoding electronic instructions for an interactive video game in such a way that the interactive video game implements the psychological strategy, loading the electronic instructions into a microprocessor-based unit equipped with a display for displaying the interactive video game and with an patient input device for receiving responses to the interactive video game from the human patient, and instructing the human patient how and when to use the microprocessor-based unit to play the interactive video game. The interactive video game contains instructions for a scoring procedure for quantitatively analyzing the medical condition of the human patient, and/or counseling instructions or self-care instructions. The video game can be used in conjunction with a physical parameter measuring device connected to the microprocessor-based unit.
    Type: Grant
    Filed: May 14, 2007
    Date of Patent: January 18, 2011
    Assignee: Health Hero Network, Inc.
    Inventor: Stephen J. Brown
  • Patent number: 7873399
    Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: January 18, 2011
    Assignee: Animas Corporation
    Inventors: Bret Berner, Chia-Ming Chiang, Michael D. Garrison, Janan Jona, Russell O. Potts, Janet A. Tamada, Michael J. Tierney
  • Patent number: 7867165
    Abstract: Method for treating a medical condition in a human patient comprising choosing a psychological strategy for treating the medical condition, encoding electronic instructions for an interactive video game in such a way that the interactive video game implements the psychological strategy, loading the electronic instructions into a microprocessor-based unit equipped with a display for displaying the interactive video game and with an patient input device for receiving responses to the interactive video game from the human patient, and instructing the human patient how and when to use the microprocessor-based unit to play the interactive video game. The interactive video game contains instructions for a scoring procedure for quantitatively analyzing the medical condition of the human patient, and/or counseling instructions or self-care instructions. The video game can be used in conjunction with a physical parameter measuring device connected to the microprocessor-based unit.
    Type: Grant
    Filed: October 19, 2006
    Date of Patent: January 11, 2011
    Assignee: Health Hero Network, Inc.
    Inventor: Stephen J. Brown
  • Patent number: 7869853
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: August 6, 2010
    Date of Patent: January 11, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 7869852
    Abstract: A method of diabetes management, comprising (a) providing a remote communications unit in communication with a portable microprocessor-based unit; (b) transmitting blood glucose level data into the portable microprocessor-based unit or the remote unit, or both; (c) running a program of instructions on the portable microprocessor-based unit or on the remote unit, or both, using data corresponding to the blood glucose level data; and (d) providing a signal including instructions to inject insulin when the blood glucose level data indicates.
    Type: Grant
    Filed: October 26, 2007
    Date of Patent: January 11, 2011
    Assignee: Health Hero Network, Inc.
    Inventor: Stephen J. Brown
  • Publication number: 20110004084
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Application
    Filed: September 17, 2010
    Publication date: January 6, 2011
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Patent number: 7862506
    Abstract: A diabetes management system, comprising a glucose meter measuring blood glucose level data and a portable microprocessor-based unit in communication with the blood glucose meter such as to be capable of accessing the blood glucose level data. Input data corresponding to the blood glucose level data is used in a program of instructions running on the portable microprocessor-based unit or the glucose meter, or both. The program of instructions includes instructions to communicate a signal to inject insulin based upon the blood glucose level data.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: January 4, 2011
    Assignee: Health Hero Network, Inc.
    Inventor: Stephen J. Brown
  • Publication number: 20100326842
    Abstract: The present disclosure provides electrode structures and integrated electrode structures having one or more conductive materials coextruded with one or more dielectric materials. The disclosed electrode structures can be configured for use as analyte sensors. Also provided, are methods of making and using the electrode structures and integrated electrode structures described herein.
    Type: Application
    Filed: June 30, 2009
    Publication date: December 30, 2010
    Inventors: John C. Mazza, Songbiao Zhang, Udo Hoss
  • Publication number: 20100331771
    Abstract: The present disclosure provides electrode structures and integrated electrode structures having one or more conductive materials coextruded with one or more dielectric materials. The disclosed electrode structures can be configured for use as analyte sensors. Also provided, are methods of making and using the electrode structures and integrated electrode structures described herein.
    Type: Application
    Filed: June 30, 2009
    Publication date: December 30, 2010
    Inventors: John C. Mazza, Songbiao Zhang, Udo Hoss, Christopher Thomas
  • Publication number: 20100331645
    Abstract: A blood glucose measuring system which comprises a blood glucose (bG) meter and a portable communication device (PCD) and methods thereof are disclosed. The blood glucose meter comprises a measurement module and a wireless module, wherein the measurement module is operable to measure the blood glucose level of a blood sample, the wireless module is an embeddable module and communicates to the measurement module via a serial interface, and the wireless module is operable to wirelessly communicate to the portable communication device. The portable communication device is operable to wirelessly receive information from the blood glucose meter related to the blood glucose measurement.
    Type: Application
    Filed: June 25, 2009
    Publication date: December 30, 2010
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Joseph Michael Simpson, Michel Cadio, Blaine Edward Ramey, James D. Tenbarge, Michael J. Blackburn, Robert G. Davies, Carol J. Batman
  • Publication number: 20100331648
    Abstract: Disclosed herein are systems and methods for calibrating a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes one or more electrodes to measure an additional analyte. Such measurements may provide a baseline or sensitivity measurement for use in calibrating the sensor. Furthermore, baseline and/or sensitivity measurements may be used to trigger events such as digital filtering of data or suspending display of data.
    Type: Application
    Filed: September 1, 2010
    Publication date: December 30, 2010
    Applicant: DexCom, Inc.
    Inventors: Apurv Ullas Kamath, Peter C. Simpson, James H. Brauker, Paul V. Goode, JR.
  • Publication number: 20100331646
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include analyte sensors designed so that at least a portion of the sensor is positionable beneath a skin surface during analyte monitoring.
    Type: Application
    Filed: June 30, 2009
    Publication date: December 30, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Benjamin Jay Feldman, Hyun Cho, Marc Barry Taub, Gary Ashley Stafford
  • Publication number: 20100331647
    Abstract: A long term analyte sensor for measuring at least one analyte in the body of a user and which includes a housing, a plurality of analyte contacting sensor elements and at least one structure for relaying information away from the sensor. This plurality of analyte contacting sensor elements are typically disposed in an array. The analyte sensor further includes at least one sensor protection membrane that is controllable in a manner such that sensor elements may be activated (e.g. exposed to the external environment) at different times so as to extend the useful life of the sensor. In illustrative analyte sensors, the analyte is glucose.
    Type: Application
    Filed: July 15, 2009
    Publication date: December 30, 2010
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Rajiv Shah, Rebecca K. Gottlieb, Eric A. Grovender, Shaun M. Pendo, Paul Citron, William P. Van Antwerp
  • Patent number: 7857759
    Abstract: Extraction device for extracting an analyte from living tissue through skin are described that include: (a) a first electrode part having a contact area with the skin of less than about 50 mm2; (b) a through-current electrode part; and (c) a power supply part for supplying electrical energy to the first electrode part and the through-current electrode part, and for extracting an analyte in the first electrode part. Analyzers, extraction methods, and analysis methods are also described.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: December 28, 2010
    Assignee: Sysmex Corporation
    Inventors: Kaoru Asano, Yasunori Maekawa, Kennichi Sawa, Toshiyuki Sato, Seiki Okada
  • Patent number: 7860544
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: December 28, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Aria Behrad, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 7860545
    Abstract: An implantable analyte-measuring device including a membrane adapted to promote vascularization and/or interfere with barrier cell layer formation. The membrane includes any combination of materials, architecture, and bioactive agents that facilitate analyte transport to provide long-term in vivo performance of the implantable analyte-measuring device.
    Type: Grant
    Filed: February 26, 2008
    Date of Patent: December 28, 2010
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, James H. Brauker, Victoria Carr-Brendel, Mark A. Tapsak, Dubravka Markovic, Stuart J. Updike, Rathbun K. Rhodes
  • Publication number: 20100324396
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: August 26, 2010
    Publication date: December 23, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 7854159
    Abstract: A sensor for measuring the concentration of components in a liquid, exhibiting a base body with a deformation body, and a hollow chamber. The hollow chamber is on the one side deformable through the deformation body and on the other side rigidly closed. The hollow chamber is completely filled with a swellable polymeric network, which network exhibits a volume phase transition at a certain concentration of components in the liquid. The liquid can have contact to the polymeric network through at least one opening in at least one of the rigid delimiting sides of the hollow chamber. A mechano electrical transducer detects the deflection of the deformation body.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: December 21, 2010
    Assignee: Technische Universität Dresden
    Inventors: Gerald Gerlach, Jörg Sorber, Margarita Günther
  • Patent number: 7846095
    Abstract: The invention is directed to lead configurations for sensors that allow for less invasive sensor replacement procedures. In one configuration, a sensor lead assembly includes an outer lead body and an inner lead including a sensor such as an electrochemical glucose sensor. The inner lead can be positioned in an inner conduit of the outer lead body. The outer lead body may be substantially permanently implanted in the patient, and the inner lead can be implanted through the inner conduit of the outer lead body. Once the sensor of the inner lead has worn out or otherwise exhausted its useful life, the inner lead can be removed, and a new inner lead can be implanted in place of the old inner lead.
    Type: Grant
    Filed: August 17, 2004
    Date of Patent: December 7, 2010
    Assignee: Medtronic, Inc.
    Inventors: Mark A. Christopherson, Nancy Perry Pool, John L. Sommer, Eric Bonde
  • Patent number: 7841993
    Abstract: A sensor and a lancet are integrated with each other. A thin strip-shaped sensor and a lancet are integrated so that the lancet moves in parallel, along a longitudinal direction of the sensor. A measuring device to which an integrated lancet and sensor is attached is provided with a function of driving the attached lancet.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: November 30, 2010
    Assignee: Panasonic Corporation
    Inventors: Shinichi Kojima, Yoshinobu Tokuno
  • Publication number: 20100298680
    Abstract: The invention relates to a measurement of tissue properties, in particular glucose, by measuring the response of the tissue to an applied electric field. The tissue is modeled by a System of homogeneous layers. In one approach, a plurality of electrical fields are generated in the tissue at different frequencies. For each of the fields, a signal depending on the dielectric permittivity as seen by the electrode arrangement at the frequency is measured, thereby generating a measured dataset. In another approach the different electrode configurations can be used to achieve different penetration depths in the desired layers. A function is then fitted to the dataset by varying at least some parameters of the function. These parameters describe the dispersion of the dielectric permittivity of a plurality of layers in the tissue. At least part of the parameters obtained in this fitting procedure are then used for determining the desired tissue property.
    Type: Application
    Filed: January 11, 2008
    Publication date: November 25, 2010
    Inventors: Mark Stuart Talary, Francois Dewarrat, Daniel Huber, Lisa Falco
  • Publication number: 20100298681
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: July 29, 2010
    Publication date: November 25, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Publication number: 20100298682
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: July 29, 2010
    Publication date: November 25, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 7837938
    Abstract: A system and method for measuring substance concentrations is provided. The system has a test strip container for receiving a test strip(s). The container has a sealing device, a counter device that counts a number of opening processes of the sealing device, a data carrier that stores batch-specific data of the test strip(s), a data transmission device for wireless transmission of the data and of the number. An analysis module has a device for measuring substance concentrations by the test strip(s), and a data-receiving device for wireless reception of the data from the data transmission device and of the number. The method records the number and stores the number on the data carrier; sends data and the number by wireless transmission to the analysis module, and determines a substance concentration by the test strip(s). Also or instead, the counter device counts a time duration of the opening processes.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: November 23, 2010
    Assignee: Rōche Diagnostics Operations, Inc.
    Inventor: Albert Wohland
  • Publication number: 20100292552
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: July 29, 2010
    Publication date: November 18, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Publication number: 20100292554
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: July 29, 2010
    Publication date: November 18, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Publication number: 20100292551
    Abstract: One aspect of the invention provides a glucose monitor having a plurality of tissue piercing elements, each tissue piercing element having a distal opening, a proximal opening and interior space extending between the distal and proximal openings; a sensing area in fluid communication with the proximal openings of the tissue piercing elements; sensing fluid extending from the sensing area into substantially the entire interior space of the tissue piercing elements; and a glucose sensor adapted to detect a concentration of glucose in the sensing fluid within the sensing area.
    Type: Application
    Filed: July 27, 2010
    Publication date: November 18, 2010
    Inventor: Arvind N. Jina
  • Publication number: 20100292553
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: July 29, 2010
    Publication date: November 18, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Publication number: 20100292555
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: July 29, 2010
    Publication date: November 18, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 7835777
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: November 16, 2010
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • Patent number: 7833157
    Abstract: A multilumen catheter having tubings extending into lumens within the catheter. The lumens may be used for blood, drugs or other medicants. The lumens may also be used for sensors. The junction element, external to the patient, connects the tubings to the lumens. The tubings, also external to the patient, connect to infusion members, to which one or more infusion systems may be connected to deliver blood, drugs and other medicants to the patient. A sensor having a sensing element may extend through the sensor lumen and be positioned internal to the patient for physiological parameter sensing. An external portion of the sensor may be connected to associated electronics to provide automatic monitoring of the physiological parameters and automatic delivery and control of the infusants.
    Type: Grant
    Filed: May 15, 2008
    Date of Patent: November 16, 2010
    Assignee: Medtronic Minimed, Inc.
    Inventors: Rebecca Gottlieb, Rajiv Shah, Mary M. Morris, Victor Giron, Michael E. Miller, Bradley J. Enegren
  • Publication number: 20100286496
    Abstract: Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure analyte or non-analyte related signal, both of which electrode include an interference domain.
    Type: Application
    Filed: July 19, 2010
    Publication date: November 11, 2010
    Applicant: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Paul V. Goode, Apurv U. Kamath, James R. Petisce, Kum Ming Woo, Melissa A. Nicholas, Robert J. Boock, Monica A. Rixman, John Burd, Rathburn K. Rhodes, Mark A. Tapsak
  • Patent number: 7828728
    Abstract: The present invention relates generally to membranes utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, the invention relates to novel silicone-hydrophilic polymer blend membranes, and to devices and implantable devices including these membranes.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: November 9, 2010
    Assignee: DexCom, Inc.
    Inventors: Robert Boock, Monica Rixman, James H. Brauker, James R. Petisce, Peter C. Simpson, Mark Brister, Mark A. Tapsak, Victoria Carr-Brendel
  • Patent number: 7831287
    Abstract: Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure additional analyte or non-analyte related signal. Such measurements may provide a background and/or sensitivity measurement(s) for use in processing sensor data and may be used to trigger events such as digital filtering of data or suspending display of data.
    Type: Grant
    Filed: April 28, 2008
    Date of Patent: November 9, 2010
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, James R. Petisce, Peter Simpson
  • Publication number: 20100280347
    Abstract: Embodiments of the invention provide analyte sensors having optimized permselective membranes and methods for making and using such sensors. Embodiments of the invention also provide analyte sensors such as those having porous matrices coated with an analyte sensing composition and methods for making and using such sensors. Illustrative embodiments include electrochemical glucose sensors having glucose oxidase coatings.
    Type: Application
    Filed: May 20, 2010
    Publication date: November 4, 2010
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Rajiv Shah, Gopikrishnan Soundararajan, Rebecca K. Gottlieb, Udo Hoss, Eric A. Grovender, Shaun M. Pendo
  • Patent number: 7826879
    Abstract: An analyte sensor system including a substrate, a first electrode disposed on a first surface of the substrate, a second electrode disposed on a second surface of the substrate, a third electrode provided in electrical contact with at least one of the first or second electrodes, where at least a portion of the first electrode and the second electrode are subcutaneously positioned in a patient, and where the third electrode is substantially entirely positioned external to the patient, and corresponding methods are provided.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: November 2, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Zenghe Liu, Benjamin J. Feldman
  • Patent number: 7826382
    Abstract: Disclosed herein are methods and systems for receiving an encoded data packet including one or more error detection bits, one or more close proximity commands, and a communication identifier, decoding the received data packet, performing error detection based on the one or more error detection bits, validating the decoded received data packet, and executing one or more routines associated with the respective one or more close proximity commands when the decoded received data packet is validated.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: November 2, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Jeffrey Mario Sicurello, Mark K. Sloan